Jiangsu Simcere Pharmaceutical Co., Ltd.

This study tested whether adding an experimental drug called BD0801 to standard chemotherapy works better than chemotherapy alone for women with recurrent ovarian cancer that has stopped responding to platinum-based drugs. It involved 421 women whose cancer returned within 6 mont…

This is a first-in-human study to check the safety and see how the body processes a new drug called SIM0278. It involved about 60 healthy volunteers in China who received injections of the drug or a placebo. The main goal was to find safe dose levels and understand how the drug m…